Oxcarbazepine

Product NDC
59651-786
Requested package NDC
59651-786-01
11-digit product format
596510786
Labeler code
59651
Product ID
59651-786_6e11231c-bc13-42e1-ac5e-097709d8b35d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Oxcarbazepine
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Aurobindo Pharma Limited
Application
ANDA219241
Marketing category
ANDA
Marketing start
2026-10-16
Substance
OXCARBAZEPINE
Active strength
300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219241-001OXCARBAZEPINEOXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2025-04-30
A219241-002OXCARBAZEPINEOXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2025-04-30
A219241-003OXCARBAZEPINEOXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2025-04-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A219241-001AB
A219241-002AB
A219241-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A219241-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORALAB2025-04-30d4dbc9d85df4…
2026-11-14 07:37:172026-10A219241-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORALAB2025-04-30d4dbc9d85df4…
2026-11-14 07:37:172026-10A219241-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORALAB2025-04-30d4dbc9d85df4…
2026-10-15 13:18:302026-09A219241-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2025-04-30c2088c7a36db…
2026-10-15 13:18:302026-09A219241-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2025-04-30c2088c7a36db…
2026-10-15 13:18:302026-09A219241-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2025-04-30c2088c7a36db…
2026-09-14 22:38:342026-08A219241-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2025-04-3084e616aacf4f…
2026-09-14 22:38:342026-08A219241-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2025-04-3084e616aacf4f…
2026-09-14 22:38:342026-08A219241-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2025-04-3084e616aacf4f…
2026-08-18 06:07:402026-07A219241-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2025-04-30caaa826d4ba7…
2026-08-18 06:07:402026-07A219241-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2025-04-30caaa826d4ba7…
2026-08-18 06:07:402026-07A219241-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2025-04-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A219241-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2025-04-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219241-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2025-04-30011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219241-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2025-04-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219241-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2025-04-3031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219241-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2025-04-3031067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219241-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2025-04-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08A219241-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2025-04-306a471c1ec25d…
2025-08-23 18:47 UTC2025-08A219241-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2025-04-306a471c1ec25d…
2025-08-23 18:47 UTC2025-08A219241-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2025-04-306a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219241-001OXCARBAZEPINE150MGTABLET, EXTENDED RELEASE / ORAL2025-04-30a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219241-002OXCARBAZEPINE300MGTABLET, EXTENDED RELEASE / ORAL2025-04-30a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219241-003OXCARBAZEPINE600MGTABLET, EXTENDED RELEASE / ORAL2025-04-30a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A219241-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A219241-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A219241-003AB1d4dbc9d85df4…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Oxcarbazepine
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OXCARBAZEPINE300 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
VZI5B1W380Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1365653Internal RxNorm lookup
1365842Internal RxNorm lookup
1365844Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
21caded0-2ed7-4f7d-9856-27ef7c1a47c8Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OxcarbazepineOXCARBAZEPINEAurobindo Pharma Limited21caded0-2ed7-4f7d-9856-27ef7c1a47c82026-07-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219241
application number: ANDA219241
ndc (package): 59651-786-01
ndc (product): 59651-786
ndc11 (package): 59651078601

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
59651-786-0159651078601100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-786-01) 2026-10-16NoNoCurrent